查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386503

先進治療市場報告：2030 年趨勢、預測與競爭分析

Advanced Therapy Medicinal Products Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

先進治療藥物的趨勢與預測

到 2030 年，全球先進治療藥物市場預計將達到 199 億美元，2024 年至 2030 年年複合成長率為 13.5%。該市場的主要促進因素是醫療保健支出的增加、慢性病盛行率的增加、有利的法規環境和政府支持的擴大。全球先進治療藥物市場前景廣闊，細胞治療、CAR-T治療、基因治療、組織工程產品市場充滿機會。

先進治療市場洞察

Lucintel 預測，由於創傷治療和再生醫學應用的採用不斷增加，組織工程產品仍將是最大的細分市場。

由於癌症、心血管疾病和神經退化性疾病等慢性病的高盛行率，北美仍然是最大的市場。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 哪個產業將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球先進治療藥物市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球先進治療藥物市場趨勢（2018-2023）與預測（2024-2030）
  • 全球先進治療藥物市場（按產品）
    • 細胞療法
    • CAR-T療法
    • 基因治療
    • 組織工程產品

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球先進治療藥物市場（按地區）
  • 北美先進治療藥物市場
  • 歐洲先進治療藥物市場
  • 亞太先進治療藥物市場
  • 其他區域先進治療藥物市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球先進治療藥物市場成長機會（按產品）
    • 按地區分類的全球先進治療市場成長機會
  • 全球先進治療藥物市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球先進治療藥物市場的產能
    • 全球先進治療收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Spark Therapeutics
  • Bluebird Bio
  • Novartis
  • UniQure
  • Celgene Corporation
  • Gilead Lifesciences
  • Kolon TissueGene
  • JCR Pharmaceuticals
  • MEDIPOST
  • Vericel Corporation
簡介目錄

Advanced Therapy Medicinal Products Trends and Forecast

The future of the global advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets. The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases, and favorable regulatory environment and growing government support.

A more than 150-page report is developed to help in your business decisions.

Advanced Therapy Medicinal Products by Segment

The study includes a forecast for the global advanced therapy medicinal products by product and region.

Advanced Therapy Medicinal Products Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Cell Therapy
  • CAR-T Therapy
  • Gene Therapy
  • Tissue Engineered Product

Advanced Therapy Medicinal Products Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Advanced Therapy Medicinal Products Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies advanced therapy medicinal products companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the advanced therapy medicinal products companies profiled in this report include-

  • Spark Therapeutics
  • Bluebird Bio
  • Novartis
  • Uniqure
  • Celgene Corporation
  • Gilead Lifesciences
  • Kolon Tissuegene
  • JCR Pharmaceuticals
  • Medipost
  • Vericel Corporation

Advanced Therapy Medicinal Products Market Insights

Lucintel forecasts that tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.

North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.

Features of the Global Advanced Therapy Medicinal Products Market

Market Size Estimates: Advanced therapy medicinal products market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Advanced therapy medicinal products size by product and region in terms of value ($B).

Regional Analysis: Advanced therapy medicinal products market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products and regions for the mucopolysaccharidosis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the advanced therapy medicinal products market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the advanced therapy medicinal products market size?

Answer: The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030.

Q.2 What is the growth forecast for advanced therapy medicinal products market?

Answer: The global advanced therapy medicinal products market is expected to grow with a CAGR of 13.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the advanced therapy medicinal products market?

Answer: The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases and favorable regulatory environment and growing government support.

Q4. What are the major segments for advanced therapy medicinal products market?

Answer: The future of the advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets.

Q5. Who are the key advanced therapy medicinal products market companies?

Answer: Some of the key advanced therapy medicinal products companies are as follows:

  • Spark Therapeutics
  • Bluebird Bio
  • Novartis
  • Uniqure
  • Celgene Corporation
  • Gilead Lifesciences
  • Kolon Tissuegene
  • JCR Pharmaceuticals
  • Medipost
  • Vericel Corporation

Q6. Which advanced therapy medicinal products market segment will be the largest in future?

Answer: Lucintel forecasts that tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.

Q7. In advanced therapy medicinal products market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the advanced therapy medicinal products market by product (cell therapy, CAR-T therapy, gene therapy, and tissue engineered product), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Advanced Therapy Medicinal Products Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Advanced Therapy Medicinal Products Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Advanced Therapy Medicinal Products Market by Product
    • 3.3.1: Cell Therapy
    • 3.3.2: CAR-T Therapy
    • 3.3.3: Gene Therapy
    • 3.3.4: Tissue Engineered Product

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Advanced Therapy Medicinal Products Market by Region
  • 4.2: North American Advanced Therapy Medicinal Products Market
  • 4.3: European Advanced Therapy Medicinal Products Market
    • 4.3.1: European Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
  • 4.4: APAC Advanced Therapy Medicinal Products Market
    • 4.4.1: APAC Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
  • 4.5: ROW Advanced Therapy Medicinal Products Market
    • 4.5.1: ROW Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Product
    • 6.1.2: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Region
  • 6.2: Emerging Trends in the Global Advanced Therapy Medicinal Products Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Advanced Therapy Medicinal Products Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Advanced Therapy Medicinal Products Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Spark Therapeutics
  • 7.2: Bluebird Bio
  • 7.3: Novartis
  • 7.4: UniQure
  • 7.5: Celgene Corporation
  • 7.6: Gilead Lifesciences
  • 7.7: Kolon TissueGene
  • 7.8: JCR Pharmaceuticals
  • 7.9: MEDIPOST
  • 7.10: Vericel Corporation